Related Experiment Video
Updated: Jun 22, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
ATRX and Its Prognostic Significance in Soft Tissue Sarcoma
Mark M Cullen1, Warren Floyd2, Bobby Dow3
1Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.
Sarcoma
|May 14, 2024
Summary
High ATRX expression indicates better survival in soft tissue sarcoma (STS). This finding suggests ATRX is a positive prognostic indicator for overall and metastasis-free survival in STS patients.
Area of Science:
- Oncology
- Molecular Pathology
Background:
- The association between ATRX (Alpha-thalassemia/mental retardation syndrome X-linked) and aggressive sarcoma phenotypes is increasingly recognized.
- Understanding prognostic markers is crucial for effective soft tissue sarcoma (STS) management.
Purpose of the Study:
- To retrospectively evaluate ATRX as a prognosticator in soft tissue sarcoma.
- To determine the association between ATRX expression and patient survival outcomes.
Main Methods:
- A retrospective study of 128 sarcomas from a single institution.
- Immunohistochemical staining for ATRX expression.
- Prognostic significance evaluated using Kaplan-Meier curves and Cox regression analysis in a cohort of 68 primary STS.
Main Results:
- High ATRX expression was a significant positive prognostic indicator for overall survival (HR: 0.38, P=0.02).
- High ATRX expression also predicted improved metastasis-free survival (HR: 0.49, P=0.05).
- These findings were consistent in both univariate and multivariate analyses.
Conclusions:
- High ATRX expression is a favorable prognostic marker for overall and metastasis-free survival in STS patients.
- Findings align with studies in osteosarcoma, suggesting ATRX loss may drive more aggressive phenotypes.
- Further prospective studies are needed to confirm the prognostic value of ATRX in STS.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...